| 摘要 |
PROBLEM TO BE SOLVED: To provide a novel hepatitis C virus (HCV) protease inhibitor compound, to provide a method for treating HCV infection using them, and to provide a method for producing such a compound.SOLUTION: The present invention discloses compounds represented by formula (I) or pharmaceutically acceptable salts, esters, or prodrugs thereof. The compounds represented by the formula (I) inhibit serine protease activity, particularly, the activity of hepatitis C virus (HCV) NS3-NS4A protease.EFFECT: The compounds interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The invention relates to a pharmaceutical composition containing the aforementioned compounds for administration to a subject suffering from HCV infection, and the pharmaceutical composition is used in the treatment of HCV infection in the subject by administering a pharmaceutical composition comprising the compounds.SELECTED DRAWING: None |
